摘要：

20-Alkylamino-steroids of the general formulae <FORM:0930676/IV(a)/1> wherein X represents a hydrogen atom or a hydroxy or acyloxy group, Y represents a hydrogen atom or a hydroxy, acyloxy or keto group, R and R4 represent a hydrogen atom or a hydroxy or acyloxy group, R1 and R2 represent a hydrogen atom or a hydroxy, acyloxy or methyl group, R3 and R5 represent a hydrogen atom or a methyl group, and Z represents an aliphatic hydrocarbon group having not more than 6 carbon atoms are prepared by hydrogenating the corresponding 20-keto compounds with the required aliphatic amine in the presence of a hydrogenation catalyst such as a platinum or nickel catalyst -particularly platinum oxide and Raney nickel. The acyloxy groups are derived from organic carboxylic acids having not more than 6 carbon atoms. The 20-alkylamino-steroids prepared by the above process may be converted into an acid addition salt such as a hydrochloride, acetate or picrate salt, and the free 20-alkylamino-steroids may be liberated therefrom by treating with a solution of alkali. A free hydroxy group in a product may be oxidised to a keto group, and an acyloxy groups in a product may be hydrolysed to a hydroxy group. The 20-alkylamino-steroids of the first general formula above may also be obtained by hydrogenerating the 20-alkylamino-steroids of the second general formula above. The 20-alkylamino-steroids of the general formulae <FORM:0930676/IV(a)/2> wherein V and T each represent hydroxy or acyloxy (as defined above) groups, and R1, R2, R3, R4, R5 and Z have the above significance (in the case of the third and fourth formulae at least one of the substituents R, R1, R2, R4 and R5 is other than hydrogen), are new compounds. 3b ,5a -Dihydroxy- 6b -methyl-11,20-allopregnan-dione is prepared by reducing 5a -hydroxy 6b - methyl- 3,11,20- allopregnantrione with sodium borohydride. 3b ,5a - Dihydroxy- 6b -methyl- 19-norallopregnan-20-one is prepared by reacting 3b -hydroxy-19-nor-5-pregnen-20-one with ethylene glycol to form 20,20-ethylenedioxy-3b -hydroxy-19-nor-5-pregnene, treating this compound with monoperphthalic acid to form 20,20-ethylenedioxy- 5a ,6a -epoxy-3b -hydroxy-19-norallopregnane, and treating this compound with methyl magnesium iodide.

展开